{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-107485","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2026-09-14T20:01:20+00:00","discovered_at":"2026-09-14T20:02:00.324969+00:00","generated_at":"2026-09-14T20:02:08.308802+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Yarrow Bioscience raises ~$161.8M in public offering of common stock","bullets":["Sold 5,769,231 shares at $26.00/share; underwriters exercised full option for 865,384 additional shares.","Net proceeds expected ~$161.8M after underwriting discounts and estimated offering expenses.","Offer led by Jefferies LLC, TD Securities (USA) LLC and Guggenheim Securities; closing expected Sept 14, 2026.","Directors and executive officers subject to 60-day lock-up; shelf registration S-3 declared effective Aug 19, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-107485","json":"https://secwatch.observer/filing/0001104659-26-107485.json","markdown":"https://secwatch.observer/filing/0001104659-26-107485.md","text":"https://secwatch.observer/filing/0001104659-26-107485.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926107485/0001104659-26-107485-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926107485/tm2624918d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T20:02:08.308802+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}